LILY CHENG to Human papillomavirus 18
This is a "connection" page, showing publications LILY CHENG has written about Human papillomavirus 18.
Connection Strength
0.054
-
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2023 02 01; 29(3):560-570.
Score: 0.054